Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 5/2007

01.09.2007 | Original Article

Is perforated marginal ulcer after the surgery of gastroduodenal ulcer associated with inadequate treatment for Helicobacter pylori eradication?

verfasst von: Bulent Aydinli, Omer Yilmaz, Gurkan Ozturk, M. Ilhan Yildigan, Nesrin Gursan, Mahmut Basoglu

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

A marginal ulcer developing after an initial operation for gastroduodenal ulcer is a serious threat to the patient, and a challenge to surgeons. Helicobacter pylori is the primary cause of peptic ulcer disease. However, its role in ulcer recurrence, especially of marginal ulcer (MU), after peptic ulcer surgery is unclear. This study aimed to determine any association between H. pylori infection and perforated MU by comparing the prevalence of H. pylori and nonsteroidal anti-inflammatory drugs (NSAIDs) use in patients with perforated (PMU) and in those with nonperforated MU (NPMU).

Study design

The study retrospectively evaluated the records of 16 patients with PMU who underwent surgical treatment and 24 patients with NPMU who underwent medical treatment in Atatürk University, School of Medicine, Department of General Surgery and Gastroenterology, between January 1995 and December 2004.

Results

The rate of H. pylori in the PMU group was significantly higher than that of the NPMU group (P < 0.01). There was a significant relationship between NSAID consumption and PMU compared with NPMU patients (P < 0.01). There was also a significant relationship between NSAID consumption and H. pylori and PMU (P < 0.01).

Conclusion

Eradication of H. pylori after the first PMU operation especially in cases with impaired hemodynamics, severe peritoneal contamination, and/or a diameter smaller than 1 cm and avoiding the use of NSAIDs will surely reduce the risk of relapsing ulcers.
Literatur
1.
Zurück zum Zitat Sapala JA, Wood MH, Sapala MA, Flake TM Jr (1998) Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg 8:505–516PubMedCrossRef Sapala JA, Wood MH, Sapala MA, Flake TM Jr (1998) Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg 8:505–516PubMedCrossRef
2.
Zurück zum Zitat Passaro E Jr, Gordon HE, Stabile BE (1976) Marginal ulcer: a guide to management. Surg Clin North Am 56:1435–1444PubMed Passaro E Jr, Gordon HE, Stabile BE (1976) Marginal ulcer: a guide to management. Surg Clin North Am 56:1435–1444PubMed
3.
Zurück zum Zitat Lublin M, McCoy M, Waldrep DJ (2006) Perforating marginal ulcers after laparoscopic gastric bypass. Surg Endosc 20:51–54PubMedCrossRef Lublin M, McCoy M, Waldrep DJ (2006) Perforating marginal ulcers after laparoscopic gastric bypass. Surg Endosc 20:51–54PubMedCrossRef
4.
Zurück zum Zitat Alhan E, Calik A, Cinel A, Kucuktulu U (1995–96) Complicated marginal ulcers after surgery for duodenal ulcer. Acta Chir Hung 35:77–85 Alhan E, Calik A, Cinel A, Kucuktulu U (1995–96) Complicated marginal ulcers after surgery for duodenal ulcer. Acta Chir Hung 35:77–85
5.
Zurück zum Zitat Turnage RH, Sarosi G, Cryer B, Spechler S, Peterson W, Feldman M (2003) Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: a systematic review. J Gastrointest Surg 7:606–626PubMedCrossRef Turnage RH, Sarosi G, Cryer B, Spechler S, Peterson W, Feldman M (2003) Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: a systematic review. J Gastrointest Surg 7:606–626PubMedCrossRef
6.
Zurück zum Zitat Hatz R, Schildberg FW (2000) Helicobacter pylori infections—are these diseases relevant for surgical treatment? Langenbeck’s Arch Surg 385:75–83CrossRef Hatz R, Schildberg FW (2000) Helicobacter pylori infections—are these diseases relevant for surgical treatment? Langenbeck’s Arch Surg 385:75–83CrossRef
7.
Zurück zum Zitat Lee YT, Sung JJ, Choi CL, Chan FK, Ng EK, Ching JY, Leung WK, Chung SC (1998) Ulcer recurrence after gastric surgery: is Helicobacter pylori the culprit? Am J Gastroenterol 93:928–931PubMedCrossRef Lee YT, Sung JJ, Choi CL, Chan FK, Ng EK, Ching JY, Leung WK, Chung SC (1998) Ulcer recurrence after gastric surgery: is Helicobacter pylori the culprit? Am J Gastroenterol 93:928–931PubMedCrossRef
8.
Zurück zum Zitat Ng EK, Lam YH, Sung JJ, Yung MY, To KF, Chan AC, Lee DW, Law BK, Lau JY, Ling TK, Lau WY, Chung SC (2000) Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg 231:153–158PubMedCrossRef Ng EK, Lam YH, Sung JJ, Yung MY, To KF, Chan AC, Lee DW, Law BK, Lau JY, Ling TK, Lau WY, Chung SC (2000) Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg 231:153–158PubMedCrossRef
9.
Zurück zum Zitat Chu KM, Kwok KF, Law SY, Tuen HH, Tung PH, Branicki FJ, Wong J (1999) Helicobacter pylori status and endoscopy follow-up of patients having a history of perforated duodenal ulcer. Gastrointest Endosc 50:58–62PubMedCrossRef Chu KM, Kwok KF, Law SY, Tuen HH, Tung PH, Branicki FJ, Wong J (1999) Helicobacter pylori status and endoscopy follow-up of patients having a history of perforated duodenal ulcer. Gastrointest Endosc 50:58–62PubMedCrossRef
10.
Zurück zum Zitat Capella JF, Capella RF (1999) Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg 9:22–27PubMedCrossRef Capella JF, Capella RF (1999) Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg 9:22–27PubMedCrossRef
11.
Zurück zum Zitat Pope GD, Goodney PP, Burchard KW, Proia RR, Olafsson A, Lacy BE, Burrows LJ (2002) Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg 12:30–33PubMedCrossRef Pope GD, Goodney PP, Burchard KW, Proia RR, Olafsson A, Lacy BE, Burrows LJ (2002) Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg 12:30–33PubMedCrossRef
12.
Zurück zum Zitat Barreras RF (1973) Calcium and gastric secretion. Gastroenterol 64:1168–1184 Barreras RF (1973) Calcium and gastric secretion. Gastroenterol 64:1168–1184
13.
Zurück zum Zitat Sarosi GA Jr, Jaiswal KR, Nwariaku FE, Asolati M, Fleming JB, Anthony T (2005) Surgical therapy of peptic ulcers in the 21st century: more common than you think. Am J Surg 190:775–779PubMedCrossRef Sarosi GA Jr, Jaiswal KR, Nwariaku FE, Asolati M, Fleming JB, Anthony T (2005) Surgical therapy of peptic ulcers in the 21st century: more common than you think. Am J Surg 190:775–779PubMedCrossRef
14.
Zurück zum Zitat Hirschowitz BI, Lanas A (1998) Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer. Gastroenterol 114:883–892CrossRef Hirschowitz BI, Lanas A (1998) Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer. Gastroenterol 114:883–892CrossRef
15.
Zurück zum Zitat Gisbert JP, Legido J, Garcia-Sanz I, Pajares JM (2004) Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis 36:116–120PubMedCrossRef Gisbert JP, Legido J, Garcia-Sanz I, Pajares JM (2004) Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis 36:116–120PubMedCrossRef
16.
Zurück zum Zitat Peetsalu M, Maaroos HI, Peetsalu A (1998) Completeness of vagotomy, Helicobacter pylori colonization and recurrent ulcer 9 and 14 years after operation in duodenal ulcer patients. Eur J Gastroenterol Hepatol 10:305–311PubMedCrossRef Peetsalu M, Maaroos HI, Peetsalu A (1998) Completeness of vagotomy, Helicobacter pylori colonization and recurrent ulcer 9 and 14 years after operation in duodenal ulcer patients. Eur J Gastroenterol Hepatol 10:305–311PubMedCrossRef
17.
Zurück zum Zitat Gisbert JP, Pajares JM (2003) Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment. Helicobacter 8:159–167PubMedCrossRef Gisbert JP, Pajares JM (2003) Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment. Helicobacter 8:159–167PubMedCrossRef
18.
Zurück zum Zitat Vergara M, Catalan M, Gisbert JP, Calvet X (2005) Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 15(21):1411–1418CrossRef Vergara M, Catalan M, Gisbert JP, Calvet X (2005) Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 15(21):1411–1418CrossRef
19.
Zurück zum Zitat Chan FK (2005) Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin? Chin J Dig Dis 6:1–5PubMedCrossRef Chan FK (2005) Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin? Chin J Dig Dis 6:1–5PubMedCrossRef
20.
Zurück zum Zitat Rodriguez-Sanjuan JC, Fernandez-Santiago R, Garcia RA, Trugeda S, Seco I, la de Torre F, Naranjo A, Gomez-Fleitas M (2005) Perforated peptic ulcer treated by simple closure and Helicobacter pylori eradication. World J Surg 29:849–852PubMedCrossRef Rodriguez-Sanjuan JC, Fernandez-Santiago R, Garcia RA, Trugeda S, Seco I, la de Torre F, Naranjo A, Gomez-Fleitas M (2005) Perforated peptic ulcer treated by simple closure and Helicobacter pylori eradication. World J Surg 29:849–852PubMedCrossRef
Metadaten
Titel
Is perforated marginal ulcer after the surgery of gastroduodenal ulcer associated with inadequate treatment for Helicobacter pylori eradication?
verfasst von
Bulent Aydinli
Omer Yilmaz
Gurkan Ozturk
M. Ilhan Yildigan
Nesrin Gursan
Mahmut Basoglu
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 5/2007
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-007-0167-4

Weitere Artikel der Ausgabe 5/2007

Langenbeck's Archives of Surgery 5/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.